Targeting JAK2 with a multifunctional nanoinhibitor for long-lasting anti-inflammatory effects and bone repair

Area of Science:

• Biomaterials Science
• Nanomedicine
• Immunology

Background:

• The JAK2/STAT3 pathway is crucial for immune balance; its dysregulation causes inflammation and bone loss.
• Existing JAK2 inhibitors are hydrophobic, limiting sustained effects and bone regeneration.
• There is a need for effective nanotherapeutics targeting JAK2 for inflammatory diseases.

Purpose of the Study:

• To design and develop novel hydrophilic calcium-doped carbon dots (Ca-CDs) as a multifunctional nanoinhibitor targeting JAK2.
• To evaluate the anti-inflammatory and bone regenerative properties of Ca-CDs.
• To assess the therapeutic potential of Ca-CDs in an inflammatory disease model.

Main Methods:

• Computer-aided drug design was used to develop Ca-CDs.
• Ca-CDs were characterized for their ability to inhibit JAK2 activation.
• The efficacy of Ca-CDs was tested in vitro and in vivo using a periodontitis model.
• Ca-CDs were incorporated into an alginate hydrogel for controlled release.

Main Results:

• Developed hydrophilic Ca-CDs effectively target and inhibit JAK2.
• Ca-CDs reduced pro-inflammatory cytokine secretion and exerted anti-inflammatory effects.
• Ca-CDs promoted bone regeneration in inflammatory conditions.
• Ca-CDs-based hydrogel enabled prolonged drug retention and controlled release.

Conclusions:

• Hydrophilic Ca-CDs are a promising nanoinhibitor for the JAK2/STAT3 pathway.
• Ca-CDs demonstrate dual anti-inflammatory and bone-regenerative capabilities.
• Ca-CDs offer a novel therapeutic strategy for JAK2-associated inflammatory diseases, including periodontitis.